Home » Novartis, Others Can’t Stop Generic Tobramycin Suit
Novartis, Others Can’t Stop Generic Tobramycin Suit
An Illinois federal judge denied an attempt by Novartis Pharmaceuticals and others to dismiss a suit they brought against Akorn over a patent for cystic fibrosis medication, finding that Akorn should still get a chance to have the patent declared invalid.
Law360
Law360
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May